Back to search

Aristotle University Of Thessaloniki (AUTH)

Μελέτη του φαινοτύπου και συσχέτιση με την πρόγνωση των ασθενών με υπερτροφική μυοκαρδιοπάθεια κορυφής

Abstract

dc:description

Hypertrophic cardiomyopathy is the most common inherited myocardial disease, characterized by otherwise unexplained myocardial hypertrophy, with a prevalence of about 1 in 500 in the general population. Clinical course is variable, ranging from asymptomatic disease to heart failure symptoms, stroke and sudden cardiac death. Apical hypertrophic cardiomyopathy is a variant of hypertrophic cardiomyopathy in which myocardial hypertrophy primarily affects the left ventricular apex. Data on the prognosis of this hypertrophic cardiomyopathy subgroup appear conflicting. Our study aims to clarify the natural history of apical hypertrophic cardiomyopathy and identify predictors of outcomes.A total of 856 patients with hypertrophic cardiomyopathy were retrospectively examined. Apical hypertrophic cardiomyopathy was defined as asymmetric left ventricular hypertrophy confined predominantly at the apex either isolated (pure type) or with co-existent hypertrophy of the interventricular septum (mixed type). Echocardiographic, clinical, and survival data were compared between apical hypertrophic cardiomyopathy and hypertrophic cardiomyopathy individuals.A total of 143 (16.7%) patients were classified as apical hypertrophic cardiomyopathy. Compared to hypertrophic cardiomyopathy, subjects with apical hypertrophic cardiomyopathy were diagnosed at an older age, had better echocardiographic indices and more comorbidities at baseline. Apical aneurysms were more prevalent amongst the apical hypertrophic cardiomyopathy phenotype (6.3% vs 1.7%, p=0.003). Functional capacity as assessed by cardiopulmonary exercise testing was also better in apical hypertrophic cardiomyopathy individuals. During a mean follow-up of 6±3 years, apical hypertrophic cardiomyopathy was characterized by lower all-cause, cardiovascular, heart failure related mortality and ventricular arrhythmic events compared to hypertrophic cardiomyopathy. Univariate analysis identified atrial fibrillation, left atrial size and HCM Risk-SCD as independent predictors of the composite outcome of overall mortality and hospitalizations for cardiovascular reasons. In multivariate analysis atrial fibrillation and HCM Risk-SCD remained as independent predictors of the outcome (HR 4.3, 95% CI 1.9-9.5 for atrial fibrillation and HR 1.2, 95% CI 1.02-1.3 for HCM Risk-SCD).In conclusion, apical hypertrophic cardiomyopathy presented with more benign prognosis and exhibited a lower rate of all-cause, cardiovascular, heart failure related mortality and ventricular arrhythmic events compared to hypertrophic cardiomyopathy in our cohort. Atrial fibrillation and HCM Risk-SCD were independent predictors of overall mortality and hospitalizations for cardiovascular reasons among apical hypertrophic cardiomyopathy.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2023

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Rouskas, Pavlos
  • Ρούσκας, Παύλος

Subjects

dc:subject × 8

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/53883

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Rouskas, Pavlos; Ρούσκας, Παύλος. Μελέτη του φαινοτύπου και συσχέτιση με την πρόγνωση των ασθενών με υπερτροφική μυοκαρδιοπάθεια κορυφής. Aristotle University Of Thessaloniki (AUTH), 2023. http://hdl.handle.net/10442/hedi/53883